Korea’s Ilyang Pharm, LegoChem Boosted By Anti-Cancer Therapy Deals
This article was originally published in PharmAsia News
Executive Summary
South Korean pharmas advance in the oncology space as Ilyang Pharm lets Colombia's Biopas sell its novel leukemia therapy Supect in 10 Latin American countries, while LegoChem Biosciences links with Fosun Pharma for development and commercialization of its antibody-drug conjugate as an anticancer therapy for the Greater China region.